β-Thalassemia and Diabetes Mellitus: Current State and Future Directions
Jalal Taneera(University of Sharjah), Mawieh Hamad(University of Sharjah), Fatheya Alkhaja, A. Hajji(University of Sharjah), Hany Dewedar, Reem Qannita(University of Sharjah), Ayah Alalami(University of Sharjah), Ola Al Shehadat(University of Sharjah), Ayah Dib(University of Sharjah), Eglal Mahgoub(University of Sharjah), Alaa Al Hajji(University of Sharjah), Mona Youssef(University of Sharjah)
Cited by 7
Related Papers
Targeting Hypoxia-Inducible Factor-1 (HIF-1) in Cancer: Emerging Therapeutic Strategies and Pathway Regulation
|Pharmaceuticals|2024|101
Reduced Expression of PLCXD3 Associates With Disruption of Glucose Sensing and Insulin Signaling in Pancreatic β-Cells
|Frontiers in Endocrinology|2019|32
Co-targeting BET bromodomain BRD4 and RAC1 suppresses growth, stemness and tumorigenesis by disrupting the c-MYC-G9a-FTH1axis and downregulation of HDAC1 in molecular subtypes of breast cancer
|International Journal of Biological Sciences|2021|29
Copine 3 “CPNE3” is a novel regulator for insulin secretion and glucose uptake in pancreatic β-cells
|Scientific Reports|2021|23
<i>GDF15</i> plays a critical role in insulin secretion in INS-1 cells and human pancreatic islets
|Experimental Biology and Medicine|2023|14